endocrinology
Medicines

Step-ups in Type 2 diabetes treatment unrelated to QOL

Concerns about quality of life and health status should not delay or prevent treatment intensification in people with type 2 diabetes, according to findings from the Fremantle Diabetes Study Phase ll. The study of 930 participants assessed at baseline and at two subsequent biennial reviews found no difference in health status or quality of life ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic